Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Vitamin D and health care costs: Results from two independent population-based cohort studies.

Hannemann A, Wallaschofski H, Nauck M, Marschall P, Flessa S, Grabe HJ, Schmidt CO, Baumeister SE.

Clin Nutr. 2018 Dec;37(6 Pt A):2149-2155. doi: 10.1016/j.clnu.2017.10.014. Epub 2017 Oct 31.

PMID:
29128341
2.
3.

Attitudes and perceptions of health care workers in Northeastern Germany about multidrug-resistant organisms.

Marschall P, Hübner NO, Maletzki S, Wilke F, Dittmann K, Kramer A.

Am J Infect Control. 2016 Jun 1;44(6):e91-4. doi: 10.1016/j.ajic.2015.12.039. Epub 2016 Feb 17.

PMID:
26897700
4.

Association of PNPLA3 rs738409 and TM6SF2 rs58542926 with health services utilization in a population-based study.

Köpp J, Fleßa S, Lieb W, Markus MRP, Teumer A, Homuth G, Wallaschofski H, Marschall P, Völzke H, Baumeister SE.

BMC Health Serv Res. 2016 Feb 3;16:41. doi: 10.1186/s12913-016-1289-6.

5.

The cost of dialysis in low and middle-income countries: a systematic review.

Mushi L, Marschall P, Fleßa S.

BMC Health Serv Res. 2015 Nov 12;15:506. doi: 10.1186/s12913-015-1166-8. Review.

6.

Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration.

Melis V, Zabke C, Stamer K, Magbagbeolu M, Schwab K, Marschall P, Veh RW, Bachmann S, Deiana S, Moreau PH, Davidson K, Harrington KA, Rickard JE, Horsley D, Garman R, Mazurkiewicz M, Niewiadomska G, Wischik CM, Harrington CR, Riedel G, Theuring F.

Cell Mol Life Sci. 2015 Jun;72(11):2199-222. doi: 10.1007/s00018-014-1804-z. Epub 2014 Dec 19.

7.

Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care.

Wagner T, Fydrich T, Stiglmayr C, Marschall P, Salize HJ, Renneberg B, Fleßa S, Roepke S.

Behav Res Ther. 2014 Oct;61:12-22. doi: 10.1016/j.brat.2014.07.004. Epub 2014 Jul 22.

PMID:
25113523
8.

Determining the impacts of hospital cost-sharing on the uninsured near-poor households in Vietnam.

Vuong DA, Flessa S, Marschall P, Ha ST, Luong KN, Busse R.

Int J Equity Health. 2014 May 17;13:40. doi: 10.1186/1475-9276-13-40.

9.

A polymorphic microsatellite repeat within the ECE-1c promoter is involved in transcriptional start site determination, human evolution, and Alzheimer's disease.

Li Y, Seidel K, Marschall P, Klein M, Hope A, Schacherl J, Schmitz J, Menk M, Schefe JH, Reinemund J, Hugel R, Walden P, Schlosser A, Volkmer R, Schimkus J, Kölsch H, Maier W, Kornhuber J, Frölich L, Klare S, Kirsch S, Schmerbach K, Scheele S, Grittner U, Zollmann F, Goldin-Lang P, Peters O, Kintscher U, Unger T, Funke-Kaiser H.

J Neurosci. 2012 Nov 21;32(47):16807-20. doi: 10.1523/JNEUROSCI.2636-12.2012.

10.

Association of IGF-I and IGFBP-3 with health care costs and hospitalization: results from a prospective observational study.

Baumeister SE, Friedrich N, Schmidt CO, Völzke H, Nauck M, Hoffmann W, Flessa S, Marschall P, Wallaschofski H.

Growth Horm IGF Res. 2011 Apr;21(2):89-95. doi: 10.1016/j.ghir.2011.02.001. Epub 2011 Mar 9.

PMID:
21393039
11.

Efficiency of primary care in rural Burkina Faso. A two-stage DEA analysis.

Marschall P, Flessa S.

Health Econ Rev. 2011 Jul 20;1(1):5. doi: 10.1186/2191-1991-1-5.

12.

Prospective association of low serum total testosterone levels with health care utilization and costs in a population-based cohort of men.

Haring R, Baumeister SE, Völzke H, Kohlmann T, Marschall P, Flessa S, Nauck M, Wallaschofski H.

Int J Androl. 2010 Dec;33(6):800-9. doi: 10.1111/j.1365-2605.2009.01029.x.

PMID:
20059581
13.

Predictive modeling of health care costs: do cardiovascular risk markers improve prediction?

Baumeister SE, Dörr M, Radke D, Nauck M, John U, Marschall P, Flea S, Schmidt CO, Alte D, Völzke H.

Eur J Cardiovasc Prev Rehabil. 2010 Jun;17(3):355-62. doi: 10.1097/HJR.0b013e328333a0b7.

PMID:
19907337
14.

Comparative cost analysis of insecticide-treated net delivery strategies: sales supported by social marketing and free distribution through antenatal care.

De Allegri M, Marschall P, Flessa S, Tiendrebéogo J, Kouyaté B, Jahn A, Müller O.

Health Policy Plan. 2010 Jan;25(1):28-38. doi: 10.1093/heapol/czp031. Epub 2009 Sep 14.

PMID:
19752178
15.

Socio-economic impact of antiviral intervention.

Flessa S, Marschall P.

Handb Exp Pharmacol. 2009;(189):347-74. doi: 10.1007/978-3-540-79086-0_13. Review.

PMID:
19048207
16.

Expanding access to primary care without additional budgets? A case study from Burkina Faso.

Marschall P, Flessa S.

Eur J Health Econ. 2008 Nov;9(4):393-403. doi: 10.1007/s10198-007-0095-9. Epub 2008 Jan 16.

PMID:
18197447
17.

Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation.

Baumeister SE, Völzke H, Marschall P, John U, Schmidt CO, Flessa S, Alte D.

Gastroenterology. 2008 Jan;134(1):85-94. Epub 2007 Oct 18.

PMID:
18005961
18.

Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans.

Sönnichsen B, Koski LB, Walsh A, Marschall P, Neumann B, Brehm M, Alleaume AM, Artelt J, Bettencourt P, Cassin E, Hewitson M, Holz C, Khan M, Lazik S, Martin C, Nitzsche B, Ruer M, Stamford J, Winzi M, Heinkel R, Röder M, Finell J, Häntsch H, Jones SJ, Jones M, Piano F, Gunsalus KC, Oegema K, Gönczy P, Coulson A, Hyman AA, Echeverri CJ.

Nature. 2005 Mar 24;434(7032):462-9.

PMID:
15791247
19.

Efficiency of de novo centromere formation in human artificial chromosomes.

Mejía JE, Alazami A, Willmott A, Marschall P, Levy E, Earnshaw WC, Larin Z.

Genomics. 2002 Mar;79(3):297-304.

PMID:
11863359
20.

Transfer of YACs up to 2.3 Mb intact into human cells with polyethylenimine.

Marschall P, Malik N, Larin Z.

Gene Ther. 1999 Sep;6(9):1634-7.

21.

Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptake.

Bramlage B, Alefelder S, Marschall P, Eckstein F.

Nucleic Acids Res. 1999 Aug 1;27(15):3159-67.

22.

The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells.

Hormes R, Homann M, Oelze I, Marschall P, Tabler M, Eckstein F, Sczakiel G.

Nucleic Acids Res. 1997 Feb 15;25(4):769-75.

23.

Inhibition of gene expression with ribozymes.

Marschall P, Thomson JB, Eckstein F.

Cell Mol Neurobiol. 1994 Oct;14(5):523-38. Review.

PMID:
7621511
24.

Design of hammerhead ribozymes for the inhibition of gene expression ex vivo by exogenous application.

Eckstein F, Aurup H, Benseler F, Heidenreich O, Marschall P, Ng M, Thomson J, Tuschl T.

Nucleic Acids Symp Ser. 1993;(29):115. No abstract available.

PMID:
8247729
25.

Self-report and stability of physical symptoms by adolescents.

Marschall P.

Adolescence. 1989 Spring;24(93):209-16.

PMID:
2728969

Supplemental Content

Loading ...
Support Center